All In MedTech

Device Trial Radar · NCT04927052

A Study to Evaluate the Safety and Efficacy of Revanesse Shape + With Lidocaine Versus Juvederm Voluma With Lidocaine for the Correction of Age-Related Midface Volume Deficit / Lipoatrophy at 6 and 12 Months Post-treatment

A Multicenter, Double-Blind, Randomized, Split-Face Study to Evaluate the Safety and Efficacy of Revanesse Shape + With Lidocaine Versus Juvederm Voluma With Lidocaine for the Correction of Age-Related Midface Volume Deficit / Lipoatrophy at 6 and 12 Months Post-treatment

Last checked: Nov 20, 2026Latest source record: Nov 29, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 136 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

136

Actual

Start

Apr 21, 2021

Primary completion

Aug 30, 2023

Study completion Aug 30, 2023

Sponsor

Lead sponsor
Prollenium Medical Technologies Inc.Not on our public-company list
Sponsor type
Industry
First posted
Jun 15, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 22 years, up to 65 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

To compare the safety and efficacy profiles of Revanesse Shape + with Lidocaine versus Juvederm Voluma with Lidocaine for subcutaneous and/or supraperiosteal injection to improve appearance through the correction of age-related mid-face volume deficit in patients 22 years of age through 65 years of age. Midface volume deficit / lipoatrophy (loss of subcutaneous adipose tissue that is most apparent in the face) may be associated with acquired conditions, the aging process, or based on genetic causes.

Conditions

  • Volume Deficit in the Mid-face

Interventions

  • Revanesse Shape + with LidocaineDevice

    Revanesse Shape + with Lidocaine. Participants had 1 cheek treated with Revanesse Shape + with Lidocaine

  • Juvederm Voluma with Lidocaine.Device

    Juvederm Voluma with Lidocaine. Participants had 1 cheek treated with Juvederm Voluma with Lidocaine

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline to Visit 6/Month 6 in the Medicis Mid-face Volume Scale (MMVS) scoreTime frame: Baseline visit to Visit 6/Month 6.

Locations

7 sites in 1 country. Site status is shown where the registry gives one.

  • Laser Rejuvenation

    Calgary, Alberta, Canada

6 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.